Number of shares outstanding for Lexicon Pharmaceuticals (LXRX)

Number of shares outstanding as of November 2026 : 437,653,000

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 437,653,000. At the end of 2024 the company had 245,390,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Lexicon Pharmaceuticals from 2015 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.24 B	0.19%
2023	0.24 B	29.78%
2022	0.18 B	26.75%
2021	0.14 B	21.69%
2020	0.12 B	15.14%
2019	0.10 B	0.33%
2018	0.10 B	0.31%
2017	0.10 B	1.48%
2016	0.10 B	0.41%
2015	0.10 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Thermo Fisher Scientific TMO	370,000,000	-15.46%	🇺🇸 USA
Illumina ILMN	151,000,000	-65.50%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	102,800,000	-76.51%	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	101,900,000	-76.72%	🇺🇸 USA
Ligand Pharmaceuticals LGND	20,063,000	-95.42%	🇺🇸 USA
Esperion Therapeutics ESPR	251,353,086	-42.57%	🇺🇸 USA
Aerie Pharmaceuticals AERI	47,819,936	-89.07%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	193,423,000	-55.80%	🇺🇸 USA
Eterna Therapeutics ERNA	1,183,000	-99.73%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions